Neuroleptic malignant syndrome (NMS) is a rare life-threatening condition, usually induced
by typical and atypical antipsychotics. A middle-aged woman with bipolar disorder and acute …

Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical
neuroleptics, has been described so far. In the past few years, there has been increased use …

Neuroleptic malignant syndrome (NMS) is a life threatening medical state complicating the
use of antipsychotic medications and other drugs that affect the dopaminergic system on …

Neuroleptic malignant syndrome'(NMS) is a diagnostic and therapeutic emergency that
poses a threat to a patient's life. It represents a rare but severe complication of neuroleptic …

Abstract Neuroleptic Malignant Syndrome (NMS) is a life threatening complication of
antipsychotic therapy. It is often assumed to be rare. Observations suggest that rather than …

Background Neuroleptic malignant syndrome (NMS) was first described six decades ago
after the introduction of neuroleptic drugs for the treatment of psychotic disorders [1]. NMS is …

The neuroleptic malignant syndrome (NMS) is a rare, life-threatening adverse drug reaction
caused by the blockade of central dopaminergic receptors by neuroleptics. Patients most …

Objective: To provide an overview of neuroleptic malignant syndrome (NMS) for the general
practitioner with the most up-to-date information on etiology, workup, and management …

IntroductionNeuroleptic malignant syndrome (NMS) may be a life-threatening neurologic
crisis primarily emerging as an idiosyncratic reaction to antipsychotic agent use, and …

Neuroleptic malignant syndrome (NMS) is a rare but life threatening condition induced by
neuroleptic medications. In severe cases, NMS can rapidly lead to death. NMS is reported …